Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy
Abstract
:1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Burchell, H.B.; Wood, E.H. Reflex orthostatic dyspnea associated with pulmonary hypotension. Am. J. Physiol. 1949, 159, 563–564. [Google Scholar]
- Seward, J.B.; Hayes, D.L.; Smith, H.C. Platypnea-orthodeoxia: Clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin. Proc. 1984, 59, 221–231. [Google Scholar] [CrossRef]
- Henkin, S.; Negrotto, S.; Pollak, P.; Cullen, M. Platypnea-Orthodeoxia Syndrome: Diagnostic Challenge and the Importance of Heightened Clinical Suspicion. Tex. Heart Inst. J. 2015, 42, 498–501. [Google Scholar] [CrossRef] [PubMed]
- Rodrigues, P.; Palma, P. Platypnea-orthodeoxia syndrome in review: Defining a new disease? Cardiology 2012, 123, 15–23. [Google Scholar] [CrossRef] [PubMed]
- Shovlin, C.L.; Chamali, B.; Santhirapala, V. Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: Associations with iron deficiency and platelets. PLoS ONE 2014, 9, e88812. [Google Scholar] [CrossRef]
- Neuvillers, L.; Masri, A.; Veugeois, A.; Diakov, C. Platypnea–orthodeoxia syndrome: Comprehensive analysis by multimodal imaging. Eur. Heart J. 2021, 42, 3995. [Google Scholar] [CrossRef]
- Crosbie, P. A rare complication of pneumonectomy: Diagnosis made by a literature search. Respir. Med. 2005, 99, 1198–1200. [Google Scholar] [CrossRef]
- Califano, R.; Hsu Julie, H.S.; Summers, Y. Platypnea-orthodeoxia syndrome following left pneumonectomy for early stage non-small cell lung cancer. Cancer Treat. Commun. 2014, 2, 1–3. [Google Scholar] [CrossRef]
- Bellato, V.; Brusa, S.; Balazona, J. Platypnea-orthodeoxia syndrome in interatrial right to left shunt postpneumonectomy. Min. Anestes. 2008, 74, 271–275. [Google Scholar]
- Porter, B.S.; Hettleman, B. Treatment of Platypnea-Orthodeoxia Syndrome in a Patient with Normal Cardiac Hemodynamics: A Review of Mechanisms with Implications for Management. Methodist DeBakey Cardiovasc. J. 2018, 14, 141–146. [Google Scholar] [CrossRef]
- Krassas, A.; Tzifa, A.; Boulia, S. Posture Dependent Hypoxia Following Lobectomy: The Achilles Tendon of the Lung Surgeon? J. Investig. Surg. 2022, 35, 180–185. [Google Scholar] [CrossRef]
- Smeenk, F.W.J.; Postmus, P.E. Interatrial right-to-left shunting developing after pulmonary resection in the absence of elevated right-sided heart pressures. Review of the literature. Chest 1993, 103, 528–531. [Google Scholar] [CrossRef]
- Marini, M.; Miniati, N.; Ambrosino, B. Dyspnoea and hypoxaemia after lung surgery: The role of interatrial right-to-left shunt. Eur. Respir. J. 2006, 28, 174–181. [Google Scholar] [CrossRef]
- Agrawal, A.; Palkar, A.; Talwar, A. The multiple dimensions of platypnea-orthodeoxia syndrome: A review. Respir. Med. 2017, 129, 31–38. [Google Scholar] [CrossRef]
- Cheng, T.O. Mechanisms of platypnea-orthodeoxia: What causes water to flow uphill? Circulation 2002, 105, e47. [Google Scholar] [CrossRef]
- Devendra, G.P.; Rane, A.A.; Krasuski, R.A. Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure. JACC Cardiovasc. Interv. 2012, 5, 416–419. [Google Scholar] [CrossRef]
- Baumgartner, F.; Omari, B.; Lee, J. Survival after trauma pneumonectomy: The pathophysiologic balance of shock resuscitation with right heart failure. Am. Surg. 1996, 62, 967–972. [Google Scholar]
- Robin, E.D.; McCauley, R.F. An analysis of platypnea-orthodeoxia syndrome including a “new” therapeutic approach. Chest 1997, 112, 1449–1451. [Google Scholar] [CrossRef]
- Othman, F.; Bailey, B.; Collins, N. Platypnea-Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease. J. Am. Heart Assoc. 2022, 11, e024609. [Google Scholar] [CrossRef]
- D’Mello, A.C.; Haji, K.; Moir, S. Platypnea-orthodeoxia syndrome after right lower lobectomy for lung cancer. Oxf. Med. Case Rep. 2019, 2019, omy049. [Google Scholar] [CrossRef]
- Sakagianni, K.; Evrenoglou, D.; Mytas, D. Platypnea-orthodeoxia syndrome related to right hemidiaphragmatic elevation and a ‘stretched’patent foramen ovale. Case Rep. 2012, 2012, bcr-2012. [Google Scholar]
- Guérin, P.; Lambert, V.; Godart, F. Transcatheter closure of patent foramen ovale in patients with platypnea-orthodeoxia: Results of a multicentric French registry. Cardiovasc. Interv. Radiol. 2005, 28, 164–168. [Google Scholar] [CrossRef] [PubMed]
- Mojadidi, M.K.; Gevorgyan, R.; Noureddin, N. The effect of patent foramen ovale closure in patients with platypnea-orthodeoxia syndrome. Catheter. Cardiovasc. Interv. 2015, 86, 701–707. [Google Scholar] [CrossRef] [PubMed]
Recovery Day | Signs and Symptoms | Blood Tests | Instrumental Investigation | Treatment | |
---|---|---|---|---|---|
Day -1 | Good clinical conditions | CBC | Hb: 12.5 g/dL WBC: 9.16 × 103 μL | ECG: sinus rhythm Echocardiography: ASA without a shunt. EF 60% SARS-CoV test: negative | |
Day 0 SURGERY | SpO2: 90–100% BP: 110/90 mmHg HR: 70 bpm | CBC ABG | Hb 9.5 g/dL WBC 13.61 × 103μL pH 7.41 pO2 68 mmHg pCO2 42 SO2 96% | Chest X-ray: incomplete right lung expansion | Single-unit blood transfusion Antibiotic therapy Oxygen therapy (nasal cannula, 4 L/min) |
Day 1 | In the morning episode of sudden desaturation (SpO2 80%) Soporose state Anisocoria SpO2: 100% BP: 90/55 mmHg HR: 70 bpm | CBC ABG | Hb: 9.8 g/dL WBC: 12.03 × 103 μL: pH 7.4 pO2 50 mmHg pCO2 41 mmHg SO2 88% | TTE: ASA without a shunt Brain CT scan: two small thalamic areas attributable to suspicious ischemic lesions EEG: stage N1–N2 sleep | Tracheobronchial toilet Corticosteroids Oxygen therapy (Venturi mask 15 L) |
Day 2 | Awake and active SpO2 100% BP: 100/60 mmHg HR: 60 bpm | CBC ABG | Hb: 8.7 g/dL WBC: 9.06 × 103 μL pH 7.4 pO2 78 mmHg pCO2 43 mmHg SO2 98% | Chest X-ray: incomplete right lung expansion Brain CT scan: stable | Single-unit blood transfusion Neuro-rehabilitation exercises |
Day 3 | Acute neurologic deficit with left-sided paralysis SpO2 100% BP: 120/70 mmHg HR: 60 bpm | CBC | Hb: 9.7 g/dL WBC: 7.71 × 103 μL | Chest X-ray: stable CT neck\brain angiography: stable | Supine position Acetylsalicylic acid 100 mg Atorvastatin 20 mg |
Day 4 | Awake and stable SpO2 100% BP: 130/90 mmHg HR: 80 bpm An episode of autonomous mobilization, with SpO2 84% | CBC ABG | Hb: 10.1 g/dL WBC: 6.51 × 103 μL pH 7.55 pO2 41 mmHg pCO2 37 mmHg sO2 85% | Chest X-ray stable | Supine position Oxygen therapy (Venturi mask 15 L) |
Day 5 | Awake and stable SpO2 100% BP: 120/70 mmHg HR: 60 bpm | CBC | Hb: 11 g/dL WBC: 5.61 × 103 μL CRP 2.76 mg/dL | Supine position Removal of basal chest drainage | |
Day 6 | Awake and stable SpO2 90–100% BP: 120/70 mmHg HR: 70 bpm | Brain CT scan: stable | Partial mobilization | ||
Day 7 | Postural dyspnea SpO2 80% BP: 120/80 mmHg HR: 110 bpm | ABG 9 am ABG 4 pm | Hb: 10.9 g/dL WBC: 7.85 × 103 μL CRP: 1.63 mg/dL pH 7.53 pO2 37 mmHg pCO2 38 mmHg Lac 2.0 mmol/L SO2: 78% Ph 7.61 pO2 37 mmHg pCO2 27 mmHg SO2 80% | Chest X-ray: stable CT chest angiography: no signs of pulmonary embolism ECG: sinus rhythm TTE: EF 60%, ASA COVID-19 test negative | Clopidogrel 75 mg Oxygen therapy (Venturi mask 15 L) |
Days 8–11 Intensive care unit | ABG | pH 7.46 pO2 126 mmHg pCO2 41 mmHg SO2 97.5% | Intensive monitoring | Noninvasive ventilation Pression support 14 cm H2O Peep3 cm H2O FiO2 35% Sildenafil 25 mg Blood transfusion | |
Days 12–15 | Awake and stable SpO2: 91–100% BP: 110/60 mmHg HR: 60–70 bpm | CBC ABG | Hb: 11.3 g/dL WBC: 7.64 × 103 μL pH 7.45 pO2 63 mmHg pCO2 40 mmHg SO2 93.3% | Chest X-ray: complete right lung expansion COVID-19 test: negative | Oxygen therapy (nasal cannula, 3–5 L/min) Removal of apical chest drainage |
Day 16 | Awake and active SpO2: 85–100% BP: 110/75 mmHg HR: 70 bpm | ABG | pH 7.46 pO2 55 mmHg pCO2 33 mmHg SO2 90.6% Lac 0.7 mmol/L | TEE: interatrial septal aneurysm 2 L according to Olivares-Reyes classification. Interatrial communication, attributable to patent foramen ovale (PFO), with the flow of microbubbles in basal portion, after intravenous injection of microbubble contrast agent Enhanced transcranial Doppler ultrasound: microemboli in the basal cerebral arteries, diagnostic for permanent right-to-left shunt. | Oxygen therapy (Venturi mask 15 L) |
Day 17 | Awake and active SpO2 100% BP: 130/70 mmHg HR: 60 bpm | Oxygen therapy (Venturi mask 15 L) | |||
Day 18 | Episode of desaturation SpO2 80% BP 100/70 mmHg HR: 95 bpm | CBC | Hb: 12.5 g/dL WBC: 8.2 × 103 μL | ECG: sinus rhythm | Bisoprolol 1.25 mg Polygeline 500 mL Oxygen therapy (Venturi mask 15 L) |
Days 19–23 | Awake and stable | CBC | Hb: 11.5 g/dL WBC: 6.93 × 103 μL CRP: 1.43 mg/dL | Chest X-rays: stable | Oxygen therapy (nasal cannula, 3 L/min) |
Day 24 | Percutaneous closure of PFO | CBC | Hb: 9.9 g/dL WBC: 6.48 × 103 μL | via transesophageal echocardiogram-guided Amplatzer Multifenestrated Septal Occluder | |
Day 25 | Awake and stable | CBC | Hb: 9.2 g/dL WBC: 6.94 × 103 μL | TTE: minimal residual shunt | |
Day 26–27 | Awake and stable in the upright position SpO2 97% | CBC | Hb: 10 g/dL WBC: 6.9 × 103 μL | Chest X-ray: stable | Rehabilitation exercises |
Day 28 | SpO2 97% BP 112/70 mmHg HR 80 bpm | Hospital discharge |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zirafa, C.C.; Lenzini, A.; Spontoni, P.; Cariello, C.; Doroni, L.; Pieroni, A.; Petronio, A.S.; Melfi, F. Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy. Surgeries 2023, 4, 164-174. https://doi.org/10.3390/surgeries4020018
Zirafa CC, Lenzini A, Spontoni P, Cariello C, Doroni L, Pieroni A, Petronio AS, Melfi F. Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy. Surgeries. 2023; 4(2):164-174. https://doi.org/10.3390/surgeries4020018
Chicago/Turabian StyleZirafa, Carmelina C., Alessandra Lenzini, Paolo Spontoni, Claudia Cariello, Luca Doroni, Adrea Pieroni, Anna S. Petronio, and Franca Melfi. 2023. "Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy" Surgeries 4, no. 2: 164-174. https://doi.org/10.3390/surgeries4020018
APA StyleZirafa, C. C., Lenzini, A., Spontoni, P., Cariello, C., Doroni, L., Pieroni, A., Petronio, A. S., & Melfi, F. (2023). Platypnea-Orthodeoxia Syndrome Manifesting as an Early Complication after Lower Bilobectomy. Surgeries, 4(2), 164-174. https://doi.org/10.3390/surgeries4020018